Determining How a Dynamic Microbiome Contributes to Cystic Fibrosis Lung Disease
确定动态微生物组如何导致囊性纤维化肺病
基本信息
- 批准号:10448246
- 负责人:
- 金额:$ 60.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-17 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAnaerobic BacteriaAntibiotic TherapyAntibioticsAutomobile DrivingBacteriaBehaviorBioinformaticsBiologicalBronchiolesCarbonCessation of lifeCharacteristicsChemicalsChemistryChronicChronic PhaseChronic lung diseaseClinicalClinical ResearchCommunitiesComplexComplicationCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDataData AnalysesDevelopmentDiseaseDropsEcosystemEnergy-Generating ResourcesEnvironmentEnzymesEpithelialEpithelial CellsEventFermentationGrowthHeightImmune responseImmune systemIndividualIntravenousIon TransportLaboratoriesLeadLiteratureLungLung diseasesLung infectionsMeasuresMetabolicMetabolismMethodsMicrobial PhysiologyMicrobial TaxonomyModelingMucous body substanceMultiomic DataMutationOralOutcomeOxygenPathologyPatientsPhysiologicalPhysiologyPlayPrediction of Response to TherapyProductionPseudomonas aeruginosaPulmonary Cystic FibrosisQuality of lifeRecoveryRegulator GenesResearch PersonnelResistanceRespiratory Tract InfectionsRoleSamplingSeveritiesShapesSourceSputumStructureSymptomsSystemTestingTreatment outcomeValidationVirulenceantimicrobialbacterial communitybronchial epitheliumclinically relevantcystic fibrosis mucuscystic fibrosis patientsdysbiosiseffective therapyefficacious treatmentexperienceimprovedin vivolaboratory experimentlung microbiomemathematical modelmembermetabolomemetabolomicsmicrobialmicrobial communitymicrobial hostmicrobiomemicrobiome sequencingmicroorganism interactionmultiple omicsneutrophilnovelpathogenpatient populationpressureprogramspulmonary functionpulmonary function declineresponsetargeted treatmenttherapy outcometreatment strategy
项目摘要
Project Summary
Pulmonary exacerbations are a pervasive complication of chronic lung infection. These events
cause an increase in symptom severity, loss of lung function and require aggressive antibiotic
treatment. While the bacterial communities in chronically infected lungs are believed to be involved in
exacerbations, there is a poor understanding of how or why this happens. Our preliminary evidence
indicates there is a dysbiotic shift that occurs during CF pulmonary exacerbation (CFPE) to
the dominance of anaerobic bacteria. This proposal attempts to further test this hypothesis
and reveal mechanisms driving microbiome dynamics during CFPEs.
Cystic Fibrosis (CF) is a chronic lung disease that is caused by mutations in the Cystic
Fibrosis Transmembrane Conductance Regulator gene (CFTR). These mutations cause a buildup of
mucus in the lungs due to disrupted epithelial ion transport. This abundant mucus plugs the
conducting airways, and due to the presence of bacteria, creates anaerobic environments. Although
poorly characterized as CF pathogens, anaerobic bacteria are ubiquitous in CF lungs and believed to
play a role in the disease. Our preliminary data indicates that there is a dysbiotic shift from pathogen
dominance to anaerobes during CFPE development. Antibiotic treatment kills these anaerobes
allowing the classic pathogens of CF, such as Pseudomonas aeruginosa, to again take over the lung.
We are able to reproduce these dynamics in the laboratory allowing us to directly study their cause.
This project will investigate CFPE microbial dynamics using clinical samples from patients, laboratory
experiments and mathematical modeling.
We will collect longitudinal sputum samples from patients through exacerbation events and
analyze the microbial taxonomic composition, host response and metabolite production. In addition,
we will use a novel culture model that mimics the CF lung environment (called the WinCF model) to
test our hypothesis in vivo. WinCF can be manipulated to test the effect of chemical and biological
perturbations on the CF microbial community structure, metabolism and virulence. We will test
multiple variables on the structure and function of the CF microbial community in an attempt to
understand the drivers of dynamics observed during exacerbations. Results from these studies will be
mathematically modeled using a recently developed model of the CF microbiome growing in mucus-
plugged bronchioles. The entire project will utilize cutting edge multi-omics methods including
microbiome sequencing, metabolomics and novel bioinformatics data analysis platforms. Our
scientific rationale is that a better understanding of what causes microbial changes during CFPEs will
lead to more efficacious and targeted therapy against pathogens.
项目摘要
肺部恶化是慢性肺部感染的一种普遍并发症。这些事件
导致症状严重程度增加,肺功能丧失,需要积极的抗生素
治疗虽然慢性感染肺部的细菌群落被认为与
对于急性加重,人们对这种情况如何发生或为什么发生的了解甚少。我们的初步证据
表明CF肺加重(CFPE)期间发生了生态失调转变,
厌氧菌的优势。本提案试图进一步检验这一假设
并揭示CFPE期间驱动微生物组动态的机制。
囊性纤维化(CF)是一种慢性肺部疾病,是由囊性纤维化基因突变引起的。
纤维化跨膜传导调节基因(CFTR)。这些突变会导致
由于上皮细胞离子转运被破坏而导致肺中的粘液。这种丰富的粘液堵塞了
由于细菌的存在,导致了厌氧环境。虽然
厌氧细菌作为CF病原体的特征不明确,但在CF肺中普遍存在,
在疾病中发挥作用。我们的初步数据表明,有一个从病原体的生态失调转变,
在CFPE发育过程中以厌氧菌为主。抗生素治疗杀死这些厌氧菌
使得CF的典型病原体如铜绿假单胞菌再次占据肺部。
我们能够在实验室中重现这些动态,使我们能够直接研究其原因。
本项目将使用来自患者的临床样本、实验室样本和来自临床样本的样本,
实验和数学建模。
我们将收集患者在急性加重事件期间的纵向痰液样本,
分析微生物的分类组成、宿主反应和代谢产物的产生。此外,本发明还提供了一种方法,
我们将使用一种模拟CF肺环境的新型培养模型(称为WinCF模型),
在体内验证我们的假设WinCF可以被操纵来测试化学和生物的影响
对CF微生物群落结构、代谢和毒力的扰动。我们将测试
CF微生物群落结构和功能的多个变量,试图
了解急性加重期间观察到的动力学驱动因素。这些研究的结果将是
使用最近开发的在粘液中生长的CF微生物组的模型进行数学建模,
堵塞的细支气管整个项目将利用尖端的多组学方法,包括
微生物组测序、代谢组学和新型生物信息学数据分析平台。我们
科学原理是,更好地了解CFPE期间导致微生物变化的原因,
导致针对病原体更有效和更有针对性的治疗。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung.
- DOI:10.1016/j.jcf.2021.11.003
- 发表时间:2022-11
- 期刊:
- 影响因子:5.2
- 作者:Sosinski, Lo M.;Martin, Christian H.;Neugebauer, Kerri A.;Ghuneim, Lydia-Ann J.;Guzior, Douglas, V;Castillo-Bahena, Alicia;Mielke, Jenna;Thomas, Ryan;McClelland, Marc;Conrad, Doug;Quinn, Robert A.
- 通讯作者:Quinn, Robert A.
Longitudinal Microbial and Molecular Dynamics in the Cystic Fibrosis Lung after Elexacaftor-Tezacaftor-Ivacaftor therapy.
Elexacaftor-Tezacaftor-Ivacaftor 治疗后囊性纤维化肺的纵向微生物和分子动力学。
- DOI:10.21203/rs.3.rs-3356170/v1
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Martin,Christian;Guzior,DouglasV;Gonzalez,CelyT;Okros,Maxwell;Mielke,Jenna;Padillo,Lienwil;Querido,Gabriel;Gil,Marissa;Thomas,Ryan;McClelland,Marc;Conrad,Doug;Widder,Stefanie;Quinn,RobertA
- 通讯作者:Quinn,RobertA
Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection.
- DOI:10.1038/s41396-022-01252-5
- 发表时间:2022-09
- 期刊:
- 影响因子:11
- 作者:Ghuneim, Lydia-Ann J.;Raghuvanshi, Ruma;Neugebauer, Kerri A.;Guzior, Douglas V.;Christian, Martin H.;Schena, Bella;Feiner, Jeremiah M.;Castillo-Bahena, Alicia;Mielke, Jenna;McClelland, Marc;Conrad, Douglas;Klapper, Isaac;Zhang, Tianyu;Quinn, Robert A.
- 通讯作者:Quinn, Robert A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Andrew Quinn其他文献
Robert Andrew Quinn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Andrew Quinn', 18)}}的其他基金
Determining How a Dynamic Microbiome Contributes to Cystic Fibrosis Lung Disease
确定动态微生物组如何导致囊性纤维化肺病
- 批准号:
9979750 - 财政年份:2019
- 资助金额:
$ 60.83万 - 项目类别:
Determining How a Dynamic Microbiome Contributes to Cystic Fibrosis Lung Disease
确定动态微生物组如何导致囊性纤维化肺病
- 批准号:
10207411 - 财政年份:2019
- 资助金额:
$ 60.83万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 60.83万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 60.83万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 60.83万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 60.83万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 60.83万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 60.83万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 60.83万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 60.83万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 60.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 60.83万 - 项目类别:
Studentship